English
French
English
French
About Us
Operations
Our Products
Programs
Contact
Natco Canada launches NAT-Everolimus Tablets
Home
NATCO Canada
Natco Canada launches NAT-Everolimus Tablets
April 6, 2023
natcopharma-wpdmn
No Comments
Natco Canada launches NAT-Everolimus Tablets
Prev Post
Natco Pharma (Canada) Inc. announces the launch of
Pr
NAT-POMALIDOMIDE Capsules, the first generic alternative to POMALYST
®
in Canada
Next Post
Natco Canada launches NAT-Eribulin Injection
Leave a Reply
Cancel reply
Your name *
Your email *
Save my name, email, and website in this browser for the next time I comment.
Comments *
Post Comment
×
